Crohn’s & Colitis Foundation Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Crohn's & Colitis Foundation Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9338
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Crohn’s & Colitis Foundation Inc (CCF) is a non-profit organization that provides treatments for crohn’s disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. It provides clinical research services, clinical trial services and paediatric clinical trial services. CCF supports ongoing research initiatives and clinical studies to encourage cooperation among investigators, research centers, and other resources. The organization works in collaboration with healthcare providers and caregivers to deliver education, awareness and support services through patient-centric education and advocacy programs to patients suffering from inflammatory bowel diseases. It partners include European Federation of Crohn’s and Ulcerative Colitis Associations, International Organization of Inflammatory Bowel Disease (IOIBD) and International Ostomy Association. CCF is headquartered in New York, the US.

Crohn’s & Colitis Foundation Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Crohn’s & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 10
Crohn’s & Colitis Foundation of America and Pfizer Enter into Agreement for Inflammatory Bowel Disease 11
Merger 12
Broad Foundations To Merge With Crohn’s & Colitis Foundation 12
Crohn’s & Colitis Foundation Inc – Key Employees 13
Crohn’s & Colitis Foundation Inc – Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Government and Public Interest 15
Oct 30, 2017: Crohn’s & Colitis Foundation Receives $5 Million to Fund Innovative Translational and Clinical IBD Research 15
Sep 11, 2017: Scientists Construct First Predictive Model of Inflammatory Bowel Disease 16
Other Significant Developments 17
Apr 11, 2018: The Crohn’s & Colitis Foundation Selects Diversigen as a Preferred Provider for Metagenomics and Microbiome Analysis Services 17
Feb 12, 2018: Crohn’s & Colitis Foundation Expands Patient-Powered Research Network 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Key Facts 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crohn's & Colitis Foundation Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 10
Crohn’s & Colitis Foundation of America and Pfizer Enter into Agreement for Inflammatory Bowel Disease 11
Broad Foundations To Merge With Crohn's & Colitis Foundation 12
Crohn's & Colitis Foundation Inc, Key Employees 13

List of Figures
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crohn's & Colitis Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Crohn’s & Colitis Foundation Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GridPoints Inc:企業の戦略的SWOT分析
    GridPoints Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Credito Emiliano SpA:企業の戦略・SWOT・財務分析
    Credito Emiliano SpA - Strategy, SWOT and Corporate Finance Report Summary Credito Emiliano SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Caris Life Sciences Inc:企業の製品パイプライン分析
    Summary Caris Life Sciences Inc (Caris Life) is a biotechnology company. The company’s molecular scientific offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make personalized treatment decisions. Its ADAPT biotargeting system, is a plat …
  • Harvard Pilgrim Health Care Inc:企業の戦略・SWOT・財務情報
    Harvard Pilgrim Health Care Inc - Strategy, SWOT and Corporate Finance Report Summary Harvard Pilgrim Health Care Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Healthcare Locums Ltd:企業の戦略的SWOT分析
    Healthcare Locums Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • HeidelbergCement AG:戦略・SWOT・企業財務分析
    HeidelbergCement AG - Strategy, SWOT and Corporate Finance Report Summary HeidelbergCement AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Physio-Control Inc-医療機器分野:企業M&A・提携分析
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Bain Capital LLC is a medical device company that offers development, manufacturing, sale and service of emergency medical response products. The company provides pre-hospital, hospital, military, and accessory and disposable products. Its …
  • Nanosphere Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection test …
  • Siemens Healthineers AG (SHL):企業の財務・戦略的SWOT分析
    Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Adecco Group AG:企業の戦略・SWOT・財務分析
    Adecco Group AG - Strategy, SWOT and Corporate Finance Report Summary Adecco Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SgurrEnergy Ltd:企業の戦略的SWOT分析
    SgurrEnergy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Gilead Sciences, Inc.:企業の戦略・SWOT・財務情報
    Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pakistan Petroleum Ltd (PPL):企業の財務・戦略的SWOT分析
    Pakistan Petroleum Ltd (PPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Urenco Ltd:企業の戦略・SWOT・財務情報
    Urenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Urenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • TheraDiag SA (ALTER):企業の財務・戦略的SWOT分析
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • PJSC MegaFon:企業のM&A・事業提携・投資動向
    PJSC MegaFon - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PJSC MegaFon Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Shri Lakshmi Cotsyn Ltd.:企業の戦略・SWOT・財務分析
    Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cathay General Bancorp:企業の戦略・SWOT・財務情報
    Cathay General Bancorp - Strategy, SWOT and Corporate Finance Report Summary Cathay General Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Crrc Corporation Limited:企業の戦略・SWOT・財務分析
    Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nord Gold SE:戦略・SWOT・企業財務分析
    Nord Gold SE - Strategy, SWOT and Corporate Finance Report Summary Nord Gold SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆